David J Gelovani Selected Research

6- chloro- 2,3,4,9- tetrahydro- 1H- carbazole- 1- carboxamide

1/2020	Noninvasive quantification of SIRT1 expression-activity and pharmacologic inhibition in a rat model of intracerebral glioma using 2-[18F]BzAHA PET/CT/MRI.
1/2019	Molecular imaging HDACs class IIa expression-activity and pharmacologic inhibition in intracerebral glioma models in rats using PET/CT/(MRI) with [18F]TFAHA.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David J Gelovani Research Topics

Disease

2	Glioma (Gliomas) 01/2020 - 01/2019
2	Neoplasms (Cancer) 01/2020 - 01/2019
1	Brain Concussion (Cerebral Concussion) 01/2022

Drug/Important Bio-Agent (IBA)

2	6-(trifluoroacetamido)-1-hexanoicanilideIBA 01/2022 - 01/2019
2	6- chloro- 2,3,4,9- tetrahydro- 1H- carbazole- 1- carboxamideIBA 01/2020 - 01/2019
2	MC1568IBA 01/2020 - 01/2019
2	Sirtuin 1IBA 01/2020 - 01/2019
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2020
1	EnzymesIBA 01/2019

Therapy/Procedure

1	Radiotherapy 01/2019